Scrip
XenoPort/Astellas's gabapentin prodrug filed for restless legs in Japan
20 November 2009
Ian Haydock
Please Login to read the full article.
20 November 2009
Ian Haydock
Astellas has submitted an approval application in Japan for gabapentin enacarbil (ASP8825) for the treatment of restless legs syndrome (RLS).
The filing triggers a $5 million milestone payment to the Japanese firm's licensor,
XenoPort, under the terms of the companies' 2005 agreement. This...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
